186 related articles for article (PubMed ID: 20400230)
21. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
[TBL] [Abstract][Full Text] [Related]
22. Cx32 formation and/or Cx32-mediated intercellular communication induces expression and function of tight junctions in hepatocytic cell line.
Kojima T; Spray DC; Kokai Y; Chiba H; Mochizuki Y; Sawada N
Exp Cell Res; 2002 May; 276(1):40-51. PubMed ID: 11978007
[TBL] [Abstract][Full Text] [Related]
23. Recruitment of pericytes and astrocytes is closely related to the formation of tight junction in developing retinal vessels.
Kim JH; Kim JH; Yu YS; Kim DH; Kim KW
J Neurosci Res; 2009 Feb; 87(3):653-9. PubMed ID: 18816791
[TBL] [Abstract][Full Text] [Related]
24. Barrier function in the peripheral and central nervous system-a review.
Reinhold AK; Rittner HL
Pflugers Arch; 2017 Jan; 469(1):123-134. PubMed ID: 27957611
[TBL] [Abstract][Full Text] [Related]
25. Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology.
Padden M; Leech S; Craig B; Kirk J; Brankin B; McQuaid S
Acta Neuropathol; 2007 Feb; 113(2):177-86. PubMed ID: 17024496
[TBL] [Abstract][Full Text] [Related]
26. Hydrogen peroxide-induced alterations of tight junction proteins in bovine brain microvascular endothelial cells.
Lee HS; Namkoong K; Kim DH; Kim KJ; Cheong YH; Kim SS; Lee WB; Kim KY
Microvasc Res; 2004 Nov; 68(3):231-8. PubMed ID: 15501242
[TBL] [Abstract][Full Text] [Related]
27. Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins.
Xie H; Xue YX; Liu LB; Liu YH
Brain Res; 2010 Mar; 1319():13-20. PubMed ID: 20083091
[TBL] [Abstract][Full Text] [Related]
28. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical localization of vascular endothelial growth factor receptors-1, -2 and -3 in human spinal cord: altered expression in amyotrophic lateral sclerosis.
Spliet WG; Aronica E; Ramkema M; Witmer AN; Schlingemann RO; de Jong JM; Troost D
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):351-9. PubMed ID: 15305980
[TBL] [Abstract][Full Text] [Related]
30. Regulation of tight junctions and loss of barrier function in pathophysiology.
Harhaj NS; Antonetti DA
Int J Biochem Cell Biol; 2004 Jul; 36(7):1206-37. PubMed ID: 15109567
[TBL] [Abstract][Full Text] [Related]
31. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic characteristics of human bone marrow-derived endothelial progenitor cells in vitro support cell effectiveness for repair of the blood-spinal cord barrier in ALS.
Garbuzova-Davis S; Ehrhart J; Mustafa H; Llauget A; Boccio KJ; Sanberg PR; Appel SH; Borlongan CV
Brain Res; 2019 Dec; 1724():146428. PubMed ID: 31493389
[TBL] [Abstract][Full Text] [Related]
33. Impaired blood-brain/spinal cord barrier in ALS patients.
Garbuzova-Davis S; Hernandez-Ontiveros DG; Rodrigues MC; Haller E; Frisina-Deyo A; Mirtyl S; Sallot S; Saporta S; Borlongan CV; Sanberg PR
Brain Res; 2012 Aug; 1469():114-28. PubMed ID: 22750125
[TBL] [Abstract][Full Text] [Related]
34. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice.
Zheng C; Sköld MK; Li J; Nennesmo I; Fadeel B; Henter JI
Biochem Biophys Res Commun; 2007 Nov; 363(4):989-93. PubMed ID: 17923114
[TBL] [Abstract][Full Text] [Related]
35. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE.
Bennett J; Basivireddy J; Kollar A; Biron KE; Reickmann P; Jefferies WA; McQuaid S
J Neuroimmunol; 2010 Dec; 229(1-2):180-91. PubMed ID: 20832870
[TBL] [Abstract][Full Text] [Related]
36. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
[TBL] [Abstract][Full Text] [Related]
37. Diabetes-related alteration of occludin expression in rat blood-spinal cord barrier.
Zhao Y; Liu X; Yu A; Zhou Y; Liu B
Cell Biochem Biophys; 2010 Dec; 58(3):141-5. PubMed ID: 20717745
[TBL] [Abstract][Full Text] [Related]
38. The blood-spinal cord barrier: morphology and clinical implications.
Bartanusz V; Jezova D; Alajajian B; Digicaylioglu M
Ann Neurol; 2011 Aug; 70(2):194-206. PubMed ID: 21674586
[TBL] [Abstract][Full Text] [Related]
39. Tight junctions in brain barriers during central nervous system inflammation.
Coisne C; Engelhardt B
Antioxid Redox Signal; 2011 Sep; 15(5):1285-303. PubMed ID: 21338320
[TBL] [Abstract][Full Text] [Related]
40. Beneficial Effects of Transplanted Human Bone Marrow Endothelial Progenitors on Functional and Cellular Components of Blood-Spinal Cord Barrier in ALS Mice.
Garbuzova-Davis S; Boccio KJ; Llauget A; Shell R; Hailu S; Mustafa H; Ehrhart J; Sanberg PR; Appel SH; Borlongan CV
eNeuro; 2021; 8(5):. PubMed ID: 34479980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
